KALAMAZOO, Mich., Sept. 3 /PRNewswire-FirstCall/ -- Stryker Corporation (NYSE:SYK) announced today that it will participate in the following investor conferences: September 15, 2009 - 8:00 a.m. Eastern Time
Morgan Stanley Global Healthcare Unplugged Conference
New York, New York September 22, 2009 - 2:00 p.m. Eastern Time
UBS Global Life Sciences Conference
New York, New York A simultaneous webcast of the Company's presentations will be available on Stryker's website at http://www.stryker.com/. The presentations for the Morgan Stanley Global Healthcare Unplugged Conference and the UBS Global Life Sciences Conference will be archived for 30 days.
Certain statements made in the presentations may constitute forward-looking statements. They will be based upon management's current expectations and will be subject to various risks and uncertainties that could cause the Company's actual results to differ materially from those expressed or implied in such statements. Such factors include, but are not limited to: further weakening of economic conditions that could adversely affect the level of demand for the Company's products; pricing pressures generally, including cost-containment measures that could adversely affect the price of or demand for the Company's products; changes in foreign exchange markets; regulatory actions; unanticipated issues arising in connection with clinical studies and otherwise that affect U.S. Food and Drug Administration approval of new products; changes in reimbursement levels from third-party payors; a significant increase in product liability claims; unfavorable resolution of income tax audits; changes in financial markets; and changes in the competitive environment. Additional information concerning these and other factors is contained in the Company's filings with the U.S. Securities and Exchange Commission, including the Company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q.
Stryker Corporation is one of the world's leading medical technology companies with the most broadly based range of products in orthopaedics and a significant presence in other medical specialties. Stryker works with respected medical professionals to help people lead more active and more satisfying lives. The Company's products include implants used in joint replacement, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation, communications and digital imaging systems; as well as patient handling and emergency medical equipment. For more information about Stryker, please visit http://www.stryker.com/. DATASOURCE: Stryker Corporation CONTACT: Katherine A. Owen, Vice President, Strategy and Investor Relations, Stryker Corporation, +1-269-385-2600 Web Site: http://www.stryker.com/
|